ACC/AHA	American College of Cardiology/American Heart Association
ACCORD	Action to Control Cardiovascular Risk in Diabetes
AIM-HIGH	Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes
ApoA-I	Apolipoprotein A-I
ApoB	Apolipoprotein B
ASCVD	Atherosclerotic Cardiovascular Disease
CEC	Cholesterol Efflux Capacity
CETP	Cholesteryl Ester Transfer Protein
CSL112	A reconstituted HDL/ApoA-I infusion therapy
DHA	Docosahexaenoic Acid
EPA	Eicosapentaenoic Acid
ESC/EAS	European Society of Cardiology/European Atherosclerosis Society
eNO	Endothelial Nitric Oxide
EVOO	extra virgin olive oil
FDA	Food and Drug Administration
FIELD	Fenofibrate Intervention and Event Lowering in Diabetes
FOURIER	Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk
HDL	High-Density Lipoprotein
HDL-C	High-Density Lipoprotein Cholesterol
HF	Heart Failure
HFpEF	Heart Failure with Preserved Ejection Fraction
HPS2-THRIVE	Heart Protection Study 2–Treatment of HDL to Reduce the Incidence of Vascular Events
IDL	Intermediate-Density Lipoprotein
ILLUMINATE	Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events
IMPROVE-IT	Improved Reduction of Outcomes: Vytorin Efficacy International Trial
JACC	Journal of the American College of Cardiology
LCAT	Lecithin–Cholesterol Acyltransferase
LDL	Low-Density Lipoprotein
LDL-C	Low-Density Lipoprotein Cholesterol
Lp(a)	Lipoprotein(a)
MetS	Metabolic Syndrome
MPO	Myeloperoxidase
Non-HDL-C	Non–High-Density Lipoprotein Cholesterol
PCSK9	Proprotein Convertase Subtilisin/Kexin Type 9
PON1	Paraoxonase-1
RCT	Reverse Cholesterol Transport
REVEAL	Randomized Evaluation of the Effects of Anacetrapib Through Lipid-modification
REDUCE-IT	Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
S1P	Sphingosine-1-Phosphate
SAA	Serum Amyloid A
sdLDL	Small Dense Low-Density Lipoprotein
sdLDL-C	Small Dense Low-Density Lipoprotein Cholesterol
SR-BI	Scavenger Receptor Class B Type I
T2DM	Type 2 Diabetes Mellitus
TZDs	Thiazolidinediones
VA-HIT	Veterans Affairs High-Density Lipoprotein Intervention Trial
VLDL	Very-Low-Density Lipoprotein